{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "OC43",
      "human coronavirus",
      "neutralization assays",
      "neutralizing antibodies"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34696505",
  "DateCompleted": {
    "Year": "2021",
    "Month": "11",
    "Day": "10"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "10",
        "Day": "14"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "2075",
      "10.3390/v13102075"
    ],
    "Journal": {
      "ISSN": "1999-4915",
      "JournalIssue": {
        "Volume": "13",
        "Issue": "10",
        "PubDate": {
          "Year": "2021",
          "Month": "Oct",
          "Day": "14"
        }
      },
      "Title": "Viruses",
      "ISOAbbreviation": "Viruses"
    },
    "ArticleTitle": "Methods to Measure Antibody Neutralization of Live Human Coronavirus OC43.",
    "Abstract": {
      "AbstractText": [
        "The human Betacoronavirus OC43 is a common cause of respiratory viral infections in adults and children. Lung infections with OC43 are associated with mortality, especially in hematopoietic stem cell transplant recipients. Neutralizing antibodies play a major role in protection against many respiratory viral infections, but to date a live viral neutralization assay for OC43 has not been described. We isolated a human monoclonal antibody (OC2) that binds to the spike protein of OC43 and neutralizes the live virus derived from the original isolate of OC43. We used this monoclonal antibody to develop and test the performance of two readily accessible in vitro assays for measuring antibody neutralization, one utilizing cytopathic effect and another utilizing an ELISA of infected cells. We used both methods to measure the neutralizing activity of the OC2 monoclonal antibody and of human plasma. These assays could prove useful for studying humoral responses to OC43 and cross-neutralization with other medically important betacoronaviruses."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0001-5858-2662"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, University of Washington, Seattle, WA 98195, USA."
          }
        ],
        "LastName": "Boonyaratanakornkit",
        "ForeName": "Jim",
        "Initials": "J"
      },
      {
        "Identifier": [
          "0000-0003-0498-9162"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA."
          }
        ],
        "LastName": "Sholukh",
        "ForeName": "Anton M",
        "Initials": "AM"
      },
      {
        "Identifier": [
          "0000-0002-4260-9784"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA."
          }
        ],
        "LastName": "Gray",
        "ForeName": "Matthew",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA."
          }
        ],
        "LastName": "Bossard",
        "ForeName": "Emily L",
        "Initials": "EL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, University of Washington, Seattle, WA 98195, USA."
          }
        ],
        "LastName": "Ford",
        "ForeName": "Emily S",
        "Initials": "ES"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA."
          }
        ],
        "LastName": "Corbett",
        "ForeName": "Kizzmekia S",
        "Initials": "KS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, University of Washington, Seattle, WA 98195, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA."
          }
        ],
        "LastName": "Corey",
        "ForeName": "Lawrence",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Immunology, University of Washington, Seattle, WA 98109, USA."
          }
        ],
        "LastName": "Taylor",
        "ForeName": "Justin J",
        "Initials": "JJ"
      }
    ],
    "GrantList": [
      {
        "GrantID": "K08 AI148588",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UM1AI068614",
        "Agency": "National Institute of Allergy and Infectious Diseases",
        "Country": ""
      },
      {
        "GrantID": "New Investigator Award",
        "Agency": "American Society for Transplantation and Cellular Therapy",
        "Country": ""
      },
      {
        "GrantID": "Evergreen Grant",
        "Agency": "Fred Hutchinson Cancer Research Center",
        "Country": ""
      },
      {
        "GrantID": "UM1 AI068614",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI134878",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "Amy Strelzer Manasevit Grant",
        "Agency": "National Marrow Donor Program",
        "Country": ""
      },
      {
        "GrantID": "Fast Grant",
        "Agency": "Emergent Ventures at George Mason University",
        "Country": ""
      },
      {
        "GrantID": "COVID pilot award",
        "Agency": "Fred Hutchinson Cancer Research Center",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Viruses",
    "NlmUniqueID": "101509722",
    "ISSNLinking": "1999-4915"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Monoclonal"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Neutralizing"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Antibodies, Monoclonal"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Antibodies, Neutralizing"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line"
    },
    {
      "QualifierName": [
        "immunology",
        "pathology",
        "virology"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [
        "immunology",
        "pathology",
        "virology"
      ],
      "DescriptorName": "Coronavirus Infections"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Coronavirus OC43, Human"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Enzyme-Linked Immunosorbent Assay"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Neutralization Tests"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    }
  ],
  "CoiStatement": "The authors declare no conflict of interest."
}